Titolo: Clinical outcomes and prognostic factors in recurrent and/or metastatic head and neck cancer patients treated with chemotherapy plus cetuximab as first-line therapy in a real-world setting
Rivista - Anno: European Journal of Cancer 2019
First author: Roberta Depenni
Sponsor: Merck
Note: Il download del paper è a pagamento